MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

August 09, 2016

In the month since a new wave of unrest began in Kashmir, Doctors Without Borders/Médecins Sans Frontières (MSF) teams have suspended their regular mental health activities in order to support health facilities treating the wounded.

March 23, 2016

Since 2006, Doctors Without Borders/Médecins Sans Frontières (MSF) has been providing ambulatory medical and psychosocial care for people in Mumbai living with drug-resistant tuberculosis (DRTB), HIV, hepatitis C, or a combination of these diseases. The majority of the patients are HIV positive who require second or third line treatment. Narendra* is one of only two percent of drug-resistant TB patients in need that have access to these new drugs.

October 31, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2014 United States Trade Representative (USTR) Special 301 Out-of-Cycle Review of India’s intellectual property legal regime and policies.

September 15, 2014

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.

June 26, 2013

MSF testifies in Congress on India's right to keep lifesaving medicines affordable.

September 27, 2012

In this blog post from BMJ Group Blogs, lawyer and India manager of MSF's Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India's medicines patent law.

September 18, 2012

Dr. Unni Karunakara, international president of Doctors Without Borders/Médecins Sans Frontières (MSF), met yesterday in Geneva with a Bahraini parliamentary delegation that included the Minister of Human Rights Dr. Salah Bin Ali Abdularahman.

Dr. Karunakara raised issues related to the need for impartial access to health care in Bahrain, and the obligation of medical staff to provide health care regardless of patients’ political or sectarian affiliations.

March 02, 2012

MSF's appeal to Novartis to drop its case against India continues as the pharmaceutical company's day in court draws near.

November 09, 2011

Kala azar, a disease transmitted by certain types of sand flies, is endemic in much of Bihar. It causes enlargement of the spleen and, if left untreated, is fatal for virtually all patients.

March 23, 2011

Across North Africa and the Middle East, MSF has been supplying and assisting hospitals and health structures where medical staff face increased numbers of injured people.

Pages

August 09, 2016

In the month since a new wave of unrest began in Kashmir, Doctors Without Borders/Médecins Sans Frontières (MSF) teams have suspended their regular mental health activities in order to support health facilities treating the wounded.

March 23, 2016

Since 2006, Doctors Without Borders/Médecins Sans Frontières (MSF) has been providing ambulatory medical and psychosocial care for people in Mumbai living with drug-resistant tuberculosis (DRTB), HIV, hepatitis C, or a combination of these diseases. The majority of the patients are HIV positive who require second or third line treatment. Narendra* is one of only two percent of drug-resistant TB patients in need that have access to these new drugs.

October 31, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2014 United States Trade Representative (USTR) Special 301 Out-of-Cycle Review of India’s intellectual property legal regime and policies.

September 15, 2014

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.

June 26, 2013

MSF testifies in Congress on India's right to keep lifesaving medicines affordable.

September 27, 2012

In this blog post from BMJ Group Blogs, lawyer and India manager of MSF's Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India's medicines patent law.

September 18, 2012

Dr. Unni Karunakara, international president of Doctors Without Borders/Médecins Sans Frontières (MSF), met yesterday in Geneva with a Bahraini parliamentary delegation that included the Minister of Human Rights Dr. Salah Bin Ali Abdularahman.

Dr. Karunakara raised issues related to the need for impartial access to health care in Bahrain, and the obligation of medical staff to provide health care regardless of patients’ political or sectarian affiliations.

March 02, 2012

MSF's appeal to Novartis to drop its case against India continues as the pharmaceutical company's day in court draws near.

November 09, 2011

Kala azar, a disease transmitted by certain types of sand flies, is endemic in much of Bihar. It causes enlargement of the spleen and, if left untreated, is fatal for virtually all patients.

March 23, 2011

Across North Africa and the Middle East, MSF has been supplying and assisting hospitals and health structures where medical staff face increased numbers of injured people.

Pages